Metzger Daniel, Li Mei, Chambon Pierre
Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC) and ICS, Illkirch, France.
Methods Mol Biol. 2005;289:329-40. doi: 10.1385/1-59259-830-7:329.
The efficient introduction of somatic mutations in a given gene at a given time and in specific cell types of the skin will greatly facilitate the studies of a number of genes expressed in the skin and the production of animal models for skin diseases. We describe here strategies and techniques to create spatiotemporally controlled somatic mutations of target genes in the skin using a conditional Cre/LoxP system. They are based on cell-specific expression of the chimeric Cre recombinase Cre-ERT2, whose activity is induced by antiestrogens such as Tamoxifen (Tam), and which is obtained by fusing the Cre recombinase with a mutated ligand binding domain of the human estrogen receptor ERalpha. As an example, we present ablation of the retinoid receptor RXRalpha in epidermal basal keratinocytes of adult mice.
在特定时间以及皮肤的特定细胞类型中高效引入某一特定基因的体细胞突变,将极大地促进对皮肤中表达的众多基因的研究,以及皮肤疾病动物模型的构建。我们在此描述了利用条件性Cre/LoxP系统在皮肤中创建靶基因时空可控体细胞突变的策略和技术。这些策略和技术基于嵌合型Cre重组酶Cre-ERT2的细胞特异性表达,其活性由他莫昔芬(Tam)等抗雌激素诱导,它是通过将Cre重组酶与人雌激素受体ERα的突变配体结合域融合而获得的。作为一个例子,我们展示了成年小鼠表皮基底角质形成细胞中类视黄醇受体RXRα的缺失。